What are the distinguishing features of a worrisome breast mass in men versus gynecomastia (Gynecomastia)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Worrisome breast masses in men differ significantly from gynecomastia, with concerning features including hard consistency, fixed position, eccentric location, unilateral presentation, associated skin changes, nipple discharge, axillary lymphadenopathy, and rapid growth, warranting prompt evaluation with imaging and possibly biopsy. The key differences between worrisome breast masses and gynecomastia are:

  • Consistency: Worrisome masses are hard, while gynecomastia is typically soft and mobile
  • Location: Worrisome masses are often eccentric, while gynecomastia is centered beneath the nipple-areolar complex
  • Bilaterality: Gynecomastia is often bilateral, while worrisome masses are more likely to be unilateral
  • Skin changes: Worrisome masses may have associated skin changes, such as dimpling, ulceration, or nipple retraction, which are lacking in gynecomastia
  • Nipple discharge: Worrisome masses may have nipple discharge, especially bloody discharge, which is uncommon in gynecomastia
  • Age: Breast cancer risk increases with age, particularly after 60 years, making it more likely in older men 1

The timing and pattern of development also differ between worrisome breast masses and gynecomastia. Gynecomastia often develops gradually in response to hormonal changes, medications, or underlying conditions, while malignant masses typically show progressive growth without regression. Any concerning features in a male breast mass warrant prompt evaluation with imaging, such as mammography or ultrasound, and possibly biopsy, as male breast cancer tends to be diagnosed at more advanced stages due to delayed recognition 1.

Some key points to consider when evaluating a male breast mass include:

  • Clinical findings consistent with gynecomastia or pseudogynecomastia do not typically require imaging 1
  • Ultrasound may not be routinely indicated in men with clinical findings consistent with gynecomastia or pseudogynecomastia, but can be useful in evaluating indeterminate breast masses 1
  • Mammography is highly sensitive and specific in distinguishing benign from malignant disease and is likely more sensitive than US at detecting breast cancer 1
  • A bilateral mammogram is routinely performed in symptomatic males to assess for symmetry and detect asymptomatic contralateral gynecomastia or nonpalpable contralateral carcinoma 1

From the Research

Features of Worrisome Breast Mass in Men vs Gynecomastia

  • A worrisome breast mass in men is often characterized by a discrete mass at mammography or ultrasonography (US) 2
  • The relationship of the mass to the nipple should be carefully assessed, with an eccentric location being highly suspicious for cancer 2
  • Secondary signs that may indicate malignancy include nipple retraction, skin ulceration or thickening, increased breast trabeculation, and axillary adenopathy 2
  • Gynecomastia, on the other hand, has a typical appearance on mammography and is the most common cause of male breast enlargement 3, 4
  • Gynecomastia is often characterized by a symmetrical, disc-shaped density centered behind the nipple-areolar complex 4

Differentiation between Benign and Malignant Masses

  • Differentiation between benign and malignant masses is critical to alleviate patient anxiety and avoid unnecessary procedures 2
  • Mammography is the initial imaging modality of choice, with ultrasonography used when a mass is detected or suspected 5, 6
  • Fine-needle aspiration cytology (FNAC) and biopsy may be necessary in cases where imaging findings are suspicious or inconclusive 3, 4
  • However, in cases with a classical appearance of gynecomastia on mammography, supplemental ultrasound, FNAC, or biopsy may be superfluous and contribute to unnecessary costs 4

Clinical Evaluation

  • A male patient with a palpable unilateral breast mass consistent with gynecomastia on the basis of historical, physical, and mammographic findings does not require surgical biopsy unless other clinical indications prevail 3
  • Lack of symptoms (pain) related to the mass is probably not helpful in deciphering gynecomastia from breast cancer 3
  • Clinical information, such as a history of medical conditions or use of medications known to cause gynecomastia, should be taken into account when evaluating a male breast mass 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Imaging characteristics of malignant lesions of the male breast.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2006

Research

Radiologic evaluation of lumps in the male breast.

Acta radiologica (Stockholm, Sweden : 1987), 2016

Research

Male Breast Disease: What the Radiologist Needs to Know.

Current problems in diagnostic radiology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.